Transcatheter Closure of Postinfarction Ventricular Septal Defects Using the New Amplatzer Muscular VSD Occluder: Results of a U.S. Registry

Ralf Holzer, David Balzer, Zahid Amin, Carlos E. Ruiz, Jeffrey Feinstein, John Bass, Michael Vance, Qi Ling Cao, Ziyad M. Hijazi

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

The objective of this study was to assess the immediate and mid-term results of transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new Amplatzer postinfarct muscular VSD device (PIMVSD). Ventricular septal rupture occurs in 0.2% of myocardial infarcts and remains associated with very high morbidity and mortality. Data were prospectively collected for 18 patients who underwent attempted device closure of postinfarction VSDs between 2000 and 2003. Five patients underwent the closure in the acute phase (within 6 days from the infarct); the remaining patients underwent closure on day 14-95 after the diagnosis of the infarct. Outcome parameters included procedural success, evidence of residual shunts on echocardiography, and occurrence of procedure-related complications. The procedure was successful in deploying a device across the VSD in 16 of 18 patients. The 30-day mortality was 28%. Eleven patients are still alive and have been followed up for a median of 332 days. Two patients required a second procedure to close a residual VSD. At the most recent outpatient follow-up, the VSD was completely closed in two patients, six patients had a trivial or small residual shunt, and two patients had a moderate residual shunt. We conclude that percutaneous device closure of postinfarction VSDs using the Amplatzer PIMVSD occluder appears to be safe and effective. Further trials are required to assess long-term efficacy and compare the results with those of surgical closure.

Original languageEnglish (US)
Pages (from-to)196-201
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Volume61
Issue number2
DOIs
StatePublished - Feb 1 2004

Fingerprint

Septal Occluder Device
Ventricular Heart Septal Defects
Registries
Equipment and Supplies
Ventricular Septal Rupture
Mortality
Echocardiography
Outpatients
Myocardial Infarction
Morbidity

Keywords

  • Catheterization
  • Device
  • Myocardial infarction
  • Ventricular septal rupture

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Transcatheter Closure of Postinfarction Ventricular Septal Defects Using the New Amplatzer Muscular VSD Occluder : Results of a U.S. Registry. / Holzer, Ralf; Balzer, David; Amin, Zahid; Ruiz, Carlos E.; Feinstein, Jeffrey; Bass, John; Vance, Michael; Cao, Qi Ling; Hijazi, Ziyad M.

In: Catheterization and Cardiovascular Interventions, Vol. 61, No. 2, 01.02.2004, p. 196-201.

Research output: Contribution to journalArticle

Holzer, Ralf ; Balzer, David ; Amin, Zahid ; Ruiz, Carlos E. ; Feinstein, Jeffrey ; Bass, John ; Vance, Michael ; Cao, Qi Ling ; Hijazi, Ziyad M. / Transcatheter Closure of Postinfarction Ventricular Septal Defects Using the New Amplatzer Muscular VSD Occluder : Results of a U.S. Registry. In: Catheterization and Cardiovascular Interventions. 2004 ; Vol. 61, No. 2. pp. 196-201.
@article{00013a327a3145ffbd1aa74c79e52031,
title = "Transcatheter Closure of Postinfarction Ventricular Septal Defects Using the New Amplatzer Muscular VSD Occluder: Results of a U.S. Registry",
abstract = "The objective of this study was to assess the immediate and mid-term results of transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new Amplatzer postinfarct muscular VSD device (PIMVSD). Ventricular septal rupture occurs in 0.2{\%} of myocardial infarcts and remains associated with very high morbidity and mortality. Data were prospectively collected for 18 patients who underwent attempted device closure of postinfarction VSDs between 2000 and 2003. Five patients underwent the closure in the acute phase (within 6 days from the infarct); the remaining patients underwent closure on day 14-95 after the diagnosis of the infarct. Outcome parameters included procedural success, evidence of residual shunts on echocardiography, and occurrence of procedure-related complications. The procedure was successful in deploying a device across the VSD in 16 of 18 patients. The 30-day mortality was 28{\%}. Eleven patients are still alive and have been followed up for a median of 332 days. Two patients required a second procedure to close a residual VSD. At the most recent outpatient follow-up, the VSD was completely closed in two patients, six patients had a trivial or small residual shunt, and two patients had a moderate residual shunt. We conclude that percutaneous device closure of postinfarction VSDs using the Amplatzer PIMVSD occluder appears to be safe and effective. Further trials are required to assess long-term efficacy and compare the results with those of surgical closure.",
keywords = "Catheterization, Device, Myocardial infarction, Ventricular septal rupture",
author = "Ralf Holzer and David Balzer and Zahid Amin and Ruiz, {Carlos E.} and Jeffrey Feinstein and John Bass and Michael Vance and Cao, {Qi Ling} and Hijazi, {Ziyad M.}",
year = "2004",
month = "2",
day = "1",
doi = "10.1002/ccd.10784",
language = "English (US)",
volume = "61",
pages = "196--201",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Transcatheter Closure of Postinfarction Ventricular Septal Defects Using the New Amplatzer Muscular VSD Occluder

T2 - Results of a U.S. Registry

AU - Holzer, Ralf

AU - Balzer, David

AU - Amin, Zahid

AU - Ruiz, Carlos E.

AU - Feinstein, Jeffrey

AU - Bass, John

AU - Vance, Michael

AU - Cao, Qi Ling

AU - Hijazi, Ziyad M.

PY - 2004/2/1

Y1 - 2004/2/1

N2 - The objective of this study was to assess the immediate and mid-term results of transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new Amplatzer postinfarct muscular VSD device (PIMVSD). Ventricular septal rupture occurs in 0.2% of myocardial infarcts and remains associated with very high morbidity and mortality. Data were prospectively collected for 18 patients who underwent attempted device closure of postinfarction VSDs between 2000 and 2003. Five patients underwent the closure in the acute phase (within 6 days from the infarct); the remaining patients underwent closure on day 14-95 after the diagnosis of the infarct. Outcome parameters included procedural success, evidence of residual shunts on echocardiography, and occurrence of procedure-related complications. The procedure was successful in deploying a device across the VSD in 16 of 18 patients. The 30-day mortality was 28%. Eleven patients are still alive and have been followed up for a median of 332 days. Two patients required a second procedure to close a residual VSD. At the most recent outpatient follow-up, the VSD was completely closed in two patients, six patients had a trivial or small residual shunt, and two patients had a moderate residual shunt. We conclude that percutaneous device closure of postinfarction VSDs using the Amplatzer PIMVSD occluder appears to be safe and effective. Further trials are required to assess long-term efficacy and compare the results with those of surgical closure.

AB - The objective of this study was to assess the immediate and mid-term results of transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new Amplatzer postinfarct muscular VSD device (PIMVSD). Ventricular septal rupture occurs in 0.2% of myocardial infarcts and remains associated with very high morbidity and mortality. Data were prospectively collected for 18 patients who underwent attempted device closure of postinfarction VSDs between 2000 and 2003. Five patients underwent the closure in the acute phase (within 6 days from the infarct); the remaining patients underwent closure on day 14-95 after the diagnosis of the infarct. Outcome parameters included procedural success, evidence of residual shunts on echocardiography, and occurrence of procedure-related complications. The procedure was successful in deploying a device across the VSD in 16 of 18 patients. The 30-day mortality was 28%. Eleven patients are still alive and have been followed up for a median of 332 days. Two patients required a second procedure to close a residual VSD. At the most recent outpatient follow-up, the VSD was completely closed in two patients, six patients had a trivial or small residual shunt, and two patients had a moderate residual shunt. We conclude that percutaneous device closure of postinfarction VSDs using the Amplatzer PIMVSD occluder appears to be safe and effective. Further trials are required to assess long-term efficacy and compare the results with those of surgical closure.

KW - Catheterization

KW - Device

KW - Myocardial infarction

KW - Ventricular septal rupture

UR - http://www.scopus.com/inward/record.url?scp=0742305172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0742305172&partnerID=8YFLogxK

U2 - 10.1002/ccd.10784

DO - 10.1002/ccd.10784

M3 - Article

C2 - 14755811

AN - SCOPUS:0742305172

VL - 61

SP - 196

EP - 201

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 2

ER -